Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LJPC 401

Next Previous
X
Search
Drug Profile

LJPC 401

Alternative Names: LJPC-401; Synthetic human hepcidin - La Jolla Pharmaceutical

Latest Information Update: 25 Aug 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator INSERM
  • Developer La Jolla Pharmaceutical Company
  • Class Anti-infectives; Antianaemics; Antimicrobial cationic peptides; Peptide hormones; Peptides; Proteins
  • Mechanism of Action Biological transport modulators; Hepcidin replacements; Hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Sickle cell anaemia; Beta-thalassaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Haemochromatosis; Iron overload

Most Recent Events

  • 22 Aug 2022 La Jolla Pharmaceutical Company has been acquired by Innoviva
  • 29 Jul 2021 La Jolla Pharmaceutical Company terminates a phase II trial in Iron overload in Australia, USA, United Kingdom, Italy, Greece, Cyprus, Lebanon, Thailand, Turkey due to lack of efficacy determined in interim efficacy (NCT03381833)
  • 25 Nov 2019 Updated efficacy data from a phase II trial in Hereditary hemochromatosis released by La Jolla Pharmaceutical

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top